… cetuximab vs. CRT in Human Papillomavirus (HPV)-positive LA oropharyngeal squamous
cell carcinoma … -free survival for RT-cetuximab combination, and therefore CRT with cisplatin …

… Phase I study of antiepidermal growth factor receptor antibody cetuximab in combination with
radiation therapy in patients with advanced head and neck cancer. J Clin Oncol 2001 Jul 1; …

… in squamous-cell carcinoma. In a preliminary study of radiotherapy plus cetuximab in patients
… Cetuximab as a single agent or combined with cisplatin was also associated with clinically …

… triple combination regimen (cetuximab/cisplatin [carboplatin]/FU) may provide a useful
therapeutic approach. A randomized trial investigating this triple combination is now warranted. …

… Platinum-based chemotherapy, fluorouracil, and cetuximab combination treatment is the
standard of care for first-line recurrent and/or metastatic (R/M) squamous cell carcinoma of the …

… combination with chemotherapy, in locally and regionally advanced head and neck squamous
cell carcinoma in combination … cell carcinoma after failing platinum-based chemotherapy. …

… In this study, the use of cetuximab combined with radiotherapy … ' argue for the use of cetuximab
combined with radiotherapy. … with cetuximab in advanced cutaneous SCC, combined with …

… This study demonstrates that the combination of cetuximab and platinum chemotherapy
has good activity in this population of platinum-refractory SCCHN patients. The primary end …

… The phase III EXTREME study demonstrated that combining cetuximab with platinum/5-…
of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M …

… /metastatic SCCHN is the combination of platinum/5-FU and cetuximab [22]. However, the
activity and tolerability of the weekly paclitaxel/cetuximab combination suggest that it may be a …